Technetium (99mTc) nofetumomab merpentan
From Wikipedia, the free encyclopedia
- The correct title of this article is Technetium (99mTc) nofetumomab merpentan. It features superscript or subscript characters that are substituted or omitted because of technical limitations.
|
Technetium (99mTc) nofetumomab merpentan?
|
|
| Therapeutic monoclonal antibody | |
| Source | Mouse |
| Target | ? |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 10.5 hours |
| Excretion | Renal (64%) |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Technetium (99mTc) nofetumomab merpentan (trade name Verluma) is a mouse monoclonal antibody used to aid in the diagnosis of lung cancer. Nofetumomab has a chelator, merpentan. It is labeled with a radioisotope, technetium-99m (99mTc).
|
||||||||||||||||||||||||||

